Pulse Biosciences, Inc (PLSE) Financials
PLSE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 65.9 million | 13.8 million |
| 2023-06-30 | 74.8 million | 14.3 million |
| 2023-03-31 | 70.2 million | 80.9 million |
| 2022-12-31 | 77.9 million | 80.1 million |
PLSE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -10.5 million | 1.8 million |
| 2023-06-30 | -9.2 million | 1.1 million |
| 2023-03-31 | -6.6 million | 896000 |
| 2022-12-31 | -8.0 million | 748000 |
PLSE Net Income
No data available :(
PLSE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 50.4 million | - | 9.4 million |
| 2023-06-30 | 58.7 million | - | 9.6 million |
| 2023-03-31 | 54.1 million | - | 9.8 million |
| 2022-12-31 | 61.1 million | - | 10.0 million |
PLSE Shares Outstanding
PLSE Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 23000 | 7.5 million | 3.8 million | - |
| 2023-06-30 | 16000 | 6.7 million | 3.5 million | - |
| 2023-03-31 | 39000 | 5.8 million | 3.7 million | - |
| 2022-12-31 | 41000 | 4.1 million | 2.6 million | 768000 |
PLSE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 266000 |
| 2023-06-30 | - | 302000 |
| 2023-03-31 | - | 302000 |
| 2022-12-31 | -9000 | 1.3 million |
PLSE
Price: $8.05
52 week price:
Earnings Per Share: -0.88 USD
P/E Ratio: -9.89
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 25600
Ebitda: -14.3 millionMarket Capitalization: 417.0 million